Literatures

Primary Site >> Esophagus Cancer

Gene >> CD274

1.
Journal:	Clin Cancer Res. 2005 Apr 15;11(8):2947-53.
Title:	Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer.
Author:	Ohigashi, Yuichiro\|Sho, Masayuki\|Yamada, Yukishige\|Tsurui, Yoshikazu\|Hamada, Kaoru\|Ikeda, Naoya\|Mizuno, Takashi\|Yoriki, Ryo\|Kashizuka, Hisanori\|Yane, Katsunari\|Tsushima, Fumihiko\|Otsuki, Noriko\|Yagita, Hideo\|Azuma, Miyuki\|Nakajima, Yoshiyuki
PMID:	15837746

2.
Journal:	Immunol Res. 2011 Aug;50(2-3):269-75.
Title:	T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.
Author:	Lu, Binfeng\|Chen, Lujun\|Liu, Lin\|Zhu, Yibei\|Wu, Changping\|Jiang, Jingting\|Zhang, Xueguang
PMID:	21717068

3.
Journal:	Int J Clin Exp Pathol. 2014 Aug 15;7(9):6015-23. eCollection 2014.
Title:	B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer.
Author:	Chen, Lujun\|Deng, Haifeng\|Lu, Mingyang\|Xu, Bin\|Wang, Qi\|Jiang, Jingting\|Wu, Changping
PMID:	25337246

4.
Journal:	PLoS One. 2015 Jun 26;10(6):e0131403.
Title:	PD-L1 and Survival in Solid Tumors: A Meta-Analysis.
Author:	Wu, Pin\|Wu, Dang\|Li, Lijun\|Chai, Ying\|Huang, Jian
PMID:	26114883

5.
Journal:	Onco Targets Ther. 2015 Sep 15;8:2617-25.
Title:	The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysis.
Author:	Huang, Baohua\|Chen, Lei\|Bao, Cuixia\|Sun, Chengming\|Li, Jie\|Wang, Lipeng\|Zhang, Xia
PMID:	26451118

6.
Journal:	J Gastrointest Oncol. 2015 Oct;6(5):561-9.
Title:	Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations.
Author:	Raufi, Alexander G\|Klempner, Samuel J
PMID:	26487950

7.
Journal:	Oncotarget. 2016 Feb 16;7(7):7913-24.
Title:	The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.
Author:	Chen, Miao-Fen\|Chen, Ping-Tsung\|Chen, Wen-Cheng\|Lu, Ming-Shian\|Lin, Paul-Yang\|Lee, Kuan Der
PMID:	26761210

8.
Journal:	Cancer Sci. 2016 Jun;107(6):726-33.
Title:	Negative influence of programmed death-1-ligands on the survival of esophageal cancer patients treated with chemotherapy.
Author:	Tanaka, Koji\|Miyata, Hiroshi\|Sugimura, Keijiro\|Kanemura, Takashi\|Hamada-Uematsu, Mika\|Mizote, Yu\|Yamasaki, Makoto\|Wada, Hisashi\|Nakajima, Kiyokazu\|Takiguchi, Shuji\|Mori, Masaki\|Doki, Yuichiro\|Tahara, Hideaki
PMID:	27015293

9.
Journal:	Onco Targets Ther. 2016 Aug 12;9:5023-39.
Title:	PD-L1 expression in human cancers and its association with clinical outcomes.
Author:	Wang, Xin\|Teng, Feifei\|Kong, Li\|Yu, Jinming
PMID:	27574444

10.
Journal:	J Clin Med. 2016 Nov 14;5(11). pii: jcm5110100.
Title:	The Future Prospects of Immune Therapy in Gastric and Esophageal Adenocarcinoma.
Author:	Shaib, Walid L\|Nammour, Jean Paul A\|Gill, Harpaul\|Mody, Mayur\|Saba, Nabil F
PMID:	27854242

11.
Journal:	Klin Onkol. 2017 Winter;31(1):35-39.
Title:	[Current Status of Checkpoint Inhibitors in the Treatment of Esophageal and Gastric Tumors - Overview of Studies].
Author:	Vrana, David\|Matzenauer, Marcel\|Melichar, Bohuslav
PMID:	29488776

12.
Journal:	Klin Onkol. 2017 Winter;30(Supplementum3):50-54.
Title:	[Checkpoint Inhibitors in the Treatment of Upper Gastrointestinal Tract Tumors].
Author:	Obermannova, R
PMID:	29239193

13.
Journal:	Ann Surg. 2017 Dec 4.
Title:	PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.
Author:	Yagi, Taisuke\|Baba, Yoshifumi\|Ishimoto, Takatsugu\|Iwatsuki, Masaaki\|Miyamoto, Yuji\|Yoshida, Naoya\|Watanabe, Masayuki\|Baba, Hideo
PMID:	29206673

14.
Journal:	Zhonghua Jie He He Hu Xi Za Zhi. 2017 Oct 12;40(10):736-743.
Title:	[Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].
Author:	Chen, Y L\|Zhao, J\|Jia, R\|Wang, H Y\|Zheng, J\|Bai, C Q\|Wang, M Z\|Xu, J M
PMID:	29050127

15.
Journal:	Cell Physiol Biochem. 2017;42(6):2267-2280.
Title:	PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer.
Author:	Chen, Lujun\|Xiong, Yuqi\|Li, Jing\|Zheng, Xiao\|Zhou, Qi\|Turner, Abbey\|Wu, Changping\|Lu, Binfeng\|Jiang, Jingting
PMID:	28848143

16.
Journal:	Ann Surg. 2017 Aug 10.
Title:	The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation.
Author:	Kelly, Ronan J\|Zaidi, Ali H\|Smith, Matthew A\|Omstead, Ashten N\|Kosovec, Juliann E\|Matsui, Daisuke\|Martin, Samantha A\|DiCarlo, Christina\|Werts, E Day\|Silverman, Jan F\|Wang, David H\|Jobe, Blair A
PMID:	28806299

17.
Journal:	Oncotarget. 2017 Jul 18;8(29):46756-46768.
Title:	Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Author:	Jesinghaus, Moritz\|Steiger, Katja\|Slotta-Huspenina, Julia\|Drecoll, Enken\|Pfarr, Nicole\|Meyer, Petra\|Konukiewitz, Bjorn\|Bettstetter, Marcus\|Wieczorek, Kathrin\|Ott, Katja\|Feith, Markus\|Langer, Rupert\|Weichert, Wilko\|Specht, Katja\|Boxberg, Melanie
PMID:	28657901

18.
Journal:	Oncol Lett. 2017 Jul;14(1):958-964.
Title:	MLH1 expression predicts the response to preoperative therapy and is associated with PD-L1 expression in esophageal cancer.
Author:	Momose, Kota\|Yamasaki, Makoto\|Tanaka, Koji\|Miyazaki, Yasuhiro\|Makino, Tomoki\|Takahashi, Tsuyoshi\|Kurokawa, Yukinori\|Nakajima, Kiyokazu\|Takiguchi, Shuji\|Mori, Masaki\|Doki, Yuichiro
PMID:	28693258

19.
Journal:	Expert Opin Biol Ther. 2017 Jun;17(6):723-733.
Title:	Promising immunotherapies for esophageal cancer.
Author:	Tanaka, Tomokazu\|Nakamura, Jun\|Noshiro, Hirokazu
PMID:	28366014

20.
Journal:	Ann Thorac Surg. 2017 Apr;103(4):1340-1349.
Title:	Targeting Immune Checkpoints in Esophageal Cancer: A High Mutational Load Tumor.
Author:	Dhupar, Rajeev\|Van Der Kraak, Lauren\|Pennathur, Arjun\|Schuchert, Matthew J\|Nason, Katie S\|Luketich, James D\|Lotze, Michael T
PMID:	28359471

21.
Journal:	Anticancer Res. 2017 Mar;37(3):1433-1441.
Title:	PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy.
Author:	Wakita, Akiyuki\|Motoyama, Satoru\|Nanjo, Hiroshi\|Sato, Yusuke\|Yoshino, Kei\|Sasaki, Tomohiko\|Kawakita, Yuta\|Liu, Jiajia\|Imai, Kazuhiro\|Saito, Hajime\|Minamiya, Yoshihiro
PMID:	28314315

22.
Journal:	World J Surg. 2017 Jul;41(7):1719-1725.
Title:	Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.
Author:	Iams, Wade T\|Villaflor, Victoria M
PMID:	28271259

23.
Journal:	Expert Rev Anticancer Ther. 2017 Jan;17(1):33-45. Epub 2016 Nov 23.
Title:	Basis for molecular diagnostics and immunotherapy for esophageal cancer.
Author:	Abdo, Joe\|Agrawal, Devendra K\|Mittal, Sumeet K
PMID:	27838937

24.
Journal:	Int J Biol Markers. 2017 Mar 2;32(1):e68-e74.
Title:	Prognostic role of PD-L1 in malignant solid tumors: a meta-analysis.
Author:	Pyo, Jung-Soo\|Kang, Guhyun\|Kim, Jung Yeon
PMID:	27470134

25.
Journal:	Clin Cancer Res. 2018 Mar 15;24(6):1296-1304.
Title:	Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma.
Author:	Huang, Jing\|Xu, Binghe\|Mo, Hongnan\|Zhang, Weilong\|Chen, Xuelian\|Wu, Dawei\|Qu, Dong\|Wang, Xingyuan\|Lan, Bo\|Yang, Beibei\|Wang, Pei\|Zhang, Hongtu\|Yang, Qing\|Jiao, Yuchen
PMID:	29358502

26.
Journal:	Oncol Lett. 2018 Apr;15(4):4988-4996.
Title:	Programmed death ligand 1 expression in esophageal cancer following definitive chemoradiotherapy: Prognostic significance and association with inflammatory biomarkers.
Author:	Tang, Yating\|Li, Guang\|Wu, Shan\|Tang, Lingrong\|Zhang, Ning\|Liu, Jinzhao\|Zhang, Shuo\|Yao, Lei
PMID:	29552135

27.
Journal:	Oncotarget. 2018 May 4;9(34):23482-23493.
Title:	Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.
Author:	Rosenberg, Ari J\|Wainwright, Derek A\|Rademaker, Alfred\|Galvez, Carlos\|Genet, Matthew\|Zhai, Lijie\|Lauing, Kristen L\|Mulcahy, Mary F\|Hayes, John P\|Odell, David D\|Horbinski, Craig\|Komanduri, Srinadh\|Tetreault, Marie-Pier\|Kim, Kwang-Youn A\|Villaflor, Victoria
PMID:	29805749

28.
Journal:	Ann Thorac Surg. 2018 Oct;106(4):1002-1007.
Title:	Programmed Death Ligand 1: A Step Toward Immunoscore for Esophageal Cancer.
Author:	Hynes, Conor F\|Kwon, Dong H\|Vadlamudi, Chaitanya\|Lofthus, Alexander\|Iwamoto, Aya\|Chahine, Joeffrey J\|Desale, Sameer\|Margolis, Marc\|Kallakury, Bhaskar V\|Watson, Thomas J\|Haddad, Nadim G\|Marshall, M Blair
PMID:	29859152

29.
Journal:	Medicine (Baltimore). 2018 Jul;97(30):e11614.
Title:	Prognostic significance of programmed death ligand-1 immunohistochemical expression in esophageal cancer: A meta-analysis of the literature.
Author:	Yu, Weiwei\|Guo, Yanmei
PMID:	30045299

30.
Journal:	J Thorac Dis. 2018 Jul;10(7):4433-4444.
Title:	Clinical relevance of PD-L1 and PD-L2 overexpression in patients with esophageal squamous cell carcinoma.
Author:	Hsieh, Chih-Cheng\|Hsu, Han-Shui\|Li, Anna Fen-Yau\|Chen, Yann-Jang
PMID:	30174892

31.
Journal:	Am Soc Clin Oncol Educ Book. 2018 May 23;(38):249-261.
Title:	What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
Author:	De Mello, Ramon Andrade\|Castelo-Branco, Luis\|Castelo-Branco, Pedro\|Pozza, Daniel Humberto\|Vermeulen, Louis\|Palacio, Sofia\|Salzberg, Matthew\|Lockhart, A Craig
PMID:	30231398

32.
Journal:	Anticancer Res. 2018 Oct;38(10):5569-5580.
Title:	Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
Author:	Park, Robin\|Williamson, Stephen\|Kasi, Anup\|Saeed, Anwaar
PMID:	30275174